Genelux GNLX
NASDAQ GNLX
$2.00 +0.02 (+1.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genelux (GNLX) Purchase of Investments (2024 - 2026)

Updated

Analysis

Genelux (GNLX) Purchase of Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Genelux 89.68 Mn 27.96 Mn - 14.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 14.40 Mn
Sep 30, 2025 5.26 Mn
Jun 30, 2025 10.54 Mn
Mar 31, 2025 2.46 Mn
Dec 31, 2024 480,000.00
Sep 30, 2024 1.98 Mn
Jun 30, 2024 23.38 Mn
Mar 31, 2024 3.16 Mn
API Access

Genelux Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=GNLX&period=max&api_key=YOUR_API_KEY